Search - tctmd.com

Displaying 401 - 420 of 3720

Sort: Relevancy | Date

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Conference News

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Michael O'Riordan

March 22, 2024

News Daily News

Peer Coaching May Help With BP Control in Rural Black Populations

Todd Neale

March 22, 2024

News Conference News CRT 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

L.A. McKeown

March 20, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

Pay Now, Save Later: Intracoronary Imaging for PCI Cost-effective Over Lifetime

Yael L. Maxwell

March 18, 2024

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Todd Neale

March 15, 2024

News Daily News

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Michael O'Riordan

March 14, 2024

News Daily News

Cognitive Impairment a Real Concern in HF Patients: HFSA

Caitlin E. Cox

March 13, 2024

News Daily News

Physicians (Mostly) Negative on Private Equity in Healthcare

Michael O'Riordan

March 13, 2024

News Daily News

With a Government Shutdown Averted, US Physicians See Relief From CMS Cuts

Yael L. Maxwell

March 12, 2024

News Conference News CRT 2024

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

L.A. McKeown

March 12, 2024

News Daily News

Occupational Hazard? CTO Cases Drive Up Operators’ BP, Heart Rates

Yael L. Maxwell

March 11, 2024

News Daily News

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

Yael L. Maxwell

March 07, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

Presenter: Kamile Cerlinskaite-Bajore

March 06, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT Abstracts 2024

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

Presenter: Timothy George

March 04, 2024

Presentation THT Abstracts 2024

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: JoAnn Lindenfeld

March 04, 2024

Advertisement

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Peer Coaching May Help With BP Control in Rural Black Populations

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Pay Now, Save Later: Intracoronary Imaging for PCI Cost-effective Over Lifetime

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Cognitive Impairment a Real Concern in HF Patients: HFSA

Physicians (Mostly) Negative on Private Equity in Healthcare

With a Government Shutdown Averted, US Physicians See Relief From CMS Cuts

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

Occupational Hazard? CTO Cases Drive Up Operators’ BP, Heart Rates

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Impact Of Rapid Up-Titration of Guideline-Directed Medical Therapies On Quality of Life: Insights From The STRONG-HF Trial

Debating the Role of T-TEER in the Sickest Patients

The Impact of Preoperative Impella Support on Left Ventricular Assist Device Survival and Quality of Life

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content